Philadelphia Business Journal |
Teva Announces Voluntary Suspension of Marketing for ZECUITY® in the U.S.
Business Wire (press release) JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries, Ltd. (NYSE and TASE:TEVA) announced today that it will voluntarily suspend sales, marketing and distribution of ZECUITY® (sumatriptan iontophoretic transdermal system). Teva has ... Teva announces suspension of marketing for ZECUITY |
June 13, 2016 at 09:01AM | marketing - Google News
Teva Announces Voluntary Suspension of Marketing for ZECUITY® in the U.S. - Business Wire (press release)
marketing - Google News
Nenhum comentário:
Postar um comentário